Home Newsfeeds JP Morgan Maintains Neutral on Coty, Raises Price Target to $9

JP Morgan Maintains Neutral on Coty, Raises Price Target to $9

JP Morgan analyst Andrea Teixeira maintains Coty (NYSE:COTY) with a Neutral and raises the price target from $8 to $9.

byBenzinga Newsdesk

January 13, 2023

1 minute read

JP Morgan analyst Andrea Teixeira maintains Coty (NYSE:COTY) with a Neutral and raises the price target from $8 to $9.

Credit Suisse Reiterates Outperform on AbCellera Biologics, Maintains $34 Price Target

By Benzinga Newsdesk

February 22, 8:33 AM

Credit Suisse analyst Tiago Fauth reiterates AbCellera Biologics (NASDAQ:ABCL) with a Outperform and maintains $34 price target.

ABCL

Pharma Company Organicell Partners With Beauty Health Focusing On Aging & Inflammation Signs

By Shivani Kumaresan

September 16, 11:14 AM

Biopharmaceutical company Organicell Regenerative Medicine Inc (OTC:OCEL) plans to expand into the skincare and haircare industries in partnership with Beauty Health Co (NASDAQ:SKIN). BeautyHealth’s…

OCEL

Denali Therapeutics Announces New Data And Expansion Of Its Blood-Brain Barrier-Crossing Enzyme Replacement Therapy Programs At WORLDSymposium

By Benzinga Newsdesk

February 7, 9:22 AM

New data show additional improvement and stabilization in clinical outcomes in MPS II with 104 weeks of tividenofusp alfa (DNL310) treatment in the open-label, single-arm Phase 1/2 study; sustained normalization of CSF

DNLI

‘Judge Denies Effort To Remove Trump From The Ballot In Washington State’ – NYTimes

By Benzinga Newsdesk

January 18, 4:00 PM

https://www.nytimes.com/2024/01/18/us/politics/trump-ballot-ruling-washington.htmlVoters had sought to disqualify the former president under the 14th Amendment, following the lead of Colorado and Maine.A judge in

DWAC

JP Morgan Maintains Neutral on Coty, Raises Price Target to $9

Related Posts

Credit Suisse Reiterates Outperform on AbCellera Biologics, Maintains $34 Price Target

Pharma Company Organicell Partners With Beauty Health Focusing On Aging & Inflammation Signs

Denali Therapeutics Announces New Data And Expansion Of Its Blood-Brain Barrier-Crossing Enzyme Replacement Therapy Programs At WORLDSymposium

‘Judge Denies Effort To Remove Trump From The Ballot In Washington State’ – NYTimes